The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Combination lapatinib and capecitabine in advanced, incurable squamous cell carcinoma of the head and neck (SCCHN).
Jared Weiss
Research Funding - GlaxoSmithKline
David N. Hayes
No relevant relationships to disclose
Kenneth M. Algazy
No relevant relationships to disclose
Arati Suvas Desai
No relevant relationships to disclose
Brenda Horn
No relevant relationships to disclose
Sara Gulino
No relevant relationships to disclose
Dale Flowers
No relevant relationships to disclose
Diane Frazee
No relevant relationships to disclose
Arthur M. Feldman
No relevant relationships to disclose
Arthur P. Staddon
No relevant relationships to disclose
Juneko E. Grilley-Olson
No relevant relationships to disclose
Roger B. Cohen
Consultant or Advisory Role - GlaxoSmithKline
Corey J. Langer
Research Funding - GlaxoSmithKline